Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04718415What this trial is testingNeoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell CarcinomaWho this might be right forOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 51
Early research (Phase 1)Looking for participantsNCT07216105What this trial is testingFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsWho this might be right forNon-Small Cell Lung CancerColorectal CancerBreast Cancer+3 more Fate Therapeutics 119
Not applicableLooking for participantsNCT02661139What this trial is testingProspective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw ReconstructionWho this might be right forHead and Neck CancerOsteonecrosisOsteoradionecrosis AZ Sint-Jan AV 55
Testing effectiveness (Phase 2)UnknownNCT04460066What this trial is testingAnti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.Who this might be right forEsophageal Cancer Lee's Pharmaceutical Limited 70
Large-scale testing (Phase 3)WithdrawnNCT04806945What this trial is testingA Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical CancerWho this might be right forCervical Cancer Shanghai Henlius Biotech
Early research (Phase 1)Study completedNCT03319459What this trial is testingFATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsWho this might be right forHER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more Fate Therapeutics 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT06508606What this trial is testingAK117 (Anti-CD47 mAb) Plus Cetuximab or AK104 (Anti-PD-1/CTLA-4 bsAb) as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma West China Hospital 20
Large-scale testing (Phase 3)Study completedNCT02083211What this trial is testingCombination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical CarcinomaWho this might be right forCervical Cancer Recurrent or PersistentPalliative TreatmentMonoclonal Antibody in Cervical Cancer Treatment National Institute of Cancerología 168
Early research (Phase 1)Ended earlyNCT02376699What this trial is testingSafety Study of SEA-CD40 in Cancer PatientsWho this might be right forCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellHodgkin Disease+17 more Seagen Inc. 159
Testing effectiveness (Phase 2)Study completedNCT05287113What this trial is testingStudy of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer Incyte Biosciences International Sàrl 176
Testing effectiveness (Phase 2)UnknownNCT05174325What this trial is testingEffectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma The First Affiliated Hospital of Soochow University 30
Early research (Phase 1)Study completedNCT00004879What this trial is testingMonoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerWho this might be right forColorectal CancerEsophageal CancerKidney Cancer+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT05290194What this trial is testingRadiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal CarcinomaWho this might be right forRadiotherapyPD-1 InhibitorCapecitabine+1 more Fifth Affiliated Hospital, Sun Yat-Sen University
Early research (Phase 1)WithdrawnNCT00025532What this trial is testingRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerWho this might be right forColorectal CancerEsophageal CancerGastric Cancer+1 more University of California, San Francisco
Not applicableLooking for participantsNCT05878964What this trial is testingEvaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.Who this might be right forLung CancerBreast CancerKidney Cancer+5 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 420
Testing effectiveness (Phase 2)Study completedNCT04732494What this trial is testingAnti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma BeiGene 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076What this trial is testingGYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or PembrolizumabWho this might be right forEndometrial CarcinomaCervix Carcinoma NETRIS Pharma 240
Testing effectiveness (Phase 2)Looking for participantsNCT06380816What this trial is testingA Phase I/II Trial of UCB4594 in Participants With Advanced CancerWho this might be right forAdvanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more Cancer Research UK 167
Testing effectiveness (Phase 2)UnknownNCT03713372What this trial is testingSafety and Efficacy of SCT200 in Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Cancer Sinocelltech Ltd. 40